Pivikto

药品简介

Originator: Piqray by Novartis · Manufacturer: Novartis Pharma. Indication & Dosage: PIVIKTO (Alpelisib) is a prescription medicine used to treat in combination with fulvestrant of postmenopausal women and men with hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutation advanced breast cancer. PIVIKTO manufactured by NOVARTIS. Alpelisib has to take orally once daily with food. Side Effects: The most common side effects of Alpelisib are: Nausea , vomiting , tiredness , change in how food tastes, loss of appetite, decreased weight, or dry skin The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。